Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar;89(3):362-9.
doi: 10.1016/j.ygeno.2006.11.004. Epub 2007 Jan 5.

Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels

Affiliations

Epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels

Folkert W Asselbergs et al. Genomics. 2007 Mar.

Abstract

Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) directly influence thrombus formation and degradation and thereby risk for arterial thrombosis. Activation of the renin-angiotensin system has been linked to the production of PAI-1 expression via the angiotensin II type 1 receptor (AT1R). In addition, bradykinin can induce the release of t-PA through a B2 receptor mechanism. In the present study, we aimed to investigate the epistatic effects of polymorphisms in genes from the renin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels in a large population-based sample (n=2527). We demonstrated a strong significant interaction within genetic variations of the bradykinin B2 gene (P=0.002) and between ACE and bradykinin B2 (p=0.003) polymorphisms on t-PA levels in females. In males, polymorphisms in the bradykinin B2 and AT1R gene showed the most strong effect on t-PA levels (P=0.006). In both females and males, the bradykinin B2 gene interacted with AT1R gene on plasma PAI-1 levels (P=0.026 and P=0.039, respectively). In addition, the current study found a borderline significant interaction between PAI 4G5G and ACE I/D on plasma t-PA and PAI-1 levels. These results support the idea that the interplay between the renin-angiotensin, bradykinin, and fibrinolytic systems might play an important role in t-PA and PAI-1 biology.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Polymorphisms of the renin-angiotensin, bradykinin, and fibrinolytic system show significant interactions on plasma t-PA and PAI-levels among females. Only the significant (p<0.05) and borderline significant (p<0.10) interactions are presented. The lines illustrate the interactions between genes and line thickness is inversely related to the significance level. The model of inheritance is given in parentheses. A: additive; D: dominant; R: recessive. For example, the BDKRB2 exon 1 I/D by BDKRB2 C181T interaction on t-PA levels involved a dominant by recessive effect with a p-value of 0.002.
Fig. 2
Fig. 2
Polymorphisms of the renin-angiotensin, bradykinin, and fibrinolytic system show significant interactions on plasma t-PA and PAI-levels among males. Only the significant (p<0.05) and borderline significant (p<0.10) interactions are presented. The lines illustrate the interactions between genes and line thickness is inversely related to the significance level. The model of inheritance is given in parentheses. A: additive; D: dominant; R: recessive. For example, the AT1R A1166C by BDKRB2 C181T interaction on t-PA levels involved a dominant by additive effect with a p-value of 0.006.
Fig. 3
Fig. 3
A consistent significant interaction is present between polymorphisms of the renin-angiotensin and bradykinin genes on plasma t-PA and PAI-1 levels among females and males. The four figures illustrate the interactions on the absolute values of the natural log transformed t-PA and PAI-1.

References

    1. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076–1079. - PubMed
    1. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165–1168. - PubMed
    1. Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int. 2000;58:251–259. - PubMed
    1. Vaughan DE, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. J Clin Invest. 1995;95:995–1001. - PMC - PubMed
    1. Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 1997;51:164–172. - PubMed

Publication types

LinkOut - more resources